Relationship between medicare's hospital compare performance measures and mortality rates

被引:379
作者
Werner, Rachel M.
Bradlow, Eric T.
机构
[1] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equit Res & Promot, Philadelphia, PA USA
[2] Univ Penn, Dept Mkt, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Stat, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Educ, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA
[6] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 296卷 / 22期
关键词
D O I
10.1001/jama.296.22.2694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context In response to concerns about the quality of care in US hospitals, the Centers for Medicare & Medicaid Services began measuring hospital performance and reporting this performance on their Web site, Hospital Compare. It is unknown whether these process performance measures are related to hospital-level outcomes. Objective To determine whether quality measured with the process measures used in Hospital Compare are correlated with and predictive of hospitals' risk-adjusted mortality rates. Design, Setting, and Participants Cross-sectional study of hospital care between January 1 and December 31, 2004, for acute myocardial infarction, heart failure, and pneumonia at acute care hospitals in the United States included on the Hospital Compare Web site. Ten process performance measures included in Hospital Compare were compared with hospital risk-adjusted mortality rates, which were measured using Medicare Part A claims data. Main Outcome Measures Condition-specific inpatient, 30-day, and 1-year risk-adjusted mortality rates. Results A total of 3657 acute care hospitals were included in the study based on their performance as reported in Hospital Compare. Across all acute myocardial infarction performance measures, the absolute reduction in risk-adjusted mortality rates between hospitals performing in the 25th percentile vs those performing in the 75th percentile was 0.005 for inpatient mortality, 0.006 for 30-day mortality, and 0.012 for 1-year mortality ( P <. 001 for each comparison). For the heart failure performance measures, the absolute mortality reduction was smaller, ranging from 0.001 for inpatient mortality ( P=. 03) to 0.002 for 1-year mortality ( P=. 08). For the pneumonia performance measures, the absolute reduction in mortality ranged from 0.001 for 30-day mortality ( P=. 05) to 0.005 for inpatient mortality ( P <. 001). Differences in mortality rates for hospitals performing in the 75th percentile on all measures within a condition vs those performing lower than the 25th percentile on all reported measures for acute myocardial infarction ranged between 0.008 ( P=. 06) and 0.018 ( P=. 008). For pneumonia, the effects ranged between 0.003 ( P=. 09) and 0.014 ( P <. 001); for heart failure, the effects ranged between - 0.013 ( P=. 06) and - 0.038 ( P=. 45). Conclusions Hospital performance measures predict small differences in hospital risk-adjusted mortality rates. Efforts should be made to develop performance measures that are tightly linked to patient outcomes.
引用
收藏
页码:2694 / 2702
页数:9
相关论文
共 62 条
[51]   Association between hospital process performance and outcomes among patients with acute coronary syndromes [J].
Peterson, ED ;
Roe, MT ;
Mulgund, J ;
DeLong, ER ;
Lytle, BL ;
Brindis, RG ;
Smith, SC ;
Pollack, CV ;
Newby, LK ;
Harrington, RA ;
Gibler, WB ;
Ohman, EM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (16) :1912-1920
[52]   EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION - RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL [J].
PFEFFER, MA ;
BRAUNWALD, E ;
MOYE, LA ;
BASTA, L ;
BROWN, EJ ;
CUDDY, TE ;
DAVIS, BR ;
GELTMAN, EM ;
GOLDMAN, S ;
FLAKER, GC ;
KLEIN, M ;
LAMAS, GA ;
PACKER, M ;
ROULEAU, J ;
ROULEAU, JL ;
RUTHERFORD, J ;
WERTHEIMER, JH ;
HAWKINS, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (10) :669-677
[53]   THE PROTECTIVE EFFICACY OF POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE [J].
SHAPIRO, ED ;
BERG, AT ;
AUSTRIAN, R ;
SCHROEDER, D ;
PARCELLS, V ;
MARGOLIS, A ;
ADAIR, RK ;
CLEMENS, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1453-1460
[54]   Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data [J].
Southern, DA ;
Quan, H ;
Ghali, WA .
MEDICAL CARE, 2004, 42 (04) :355-360
[55]   ESTIMATION OF THE MEAN OF A MULTIVARIATE NORMAL-DISTRIBUTION [J].
STEIN, CM .
ANNALS OF STATISTICS, 1981, 9 (06) :1135-1151
[56]   Comparison of the performance of two comorbidity measures, with and without information from prior hospitalizations [J].
Stukenborg, GJ ;
Wagner, DP ;
Connors, AF .
MEDICAL CARE, 2001, 39 (07) :727-739
[57]  
SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429
[58]  
*US GOV ACC OFF, 2006, PUBL US GOV ACC OFF
[59]  
*US NEWS WORLD REP, AM BEST HOSP
[60]   The unintended consequences of publicly reporting quality information [J].
Werner, RM ;
Asch, DA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (10) :1239-1244